X4 Pharmaceuticals (XFOR) EBIT Margin Growth (1y) (2025 - 2026)

X4 Pharmaceuticals (XFOR) EBIT Margin Growth (1y) (2025 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin Growth (1y) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -143.00
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 78.00
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 1,049.00
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 1,238.00
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -10,520.00
7 Royalty Pharma 33.72 Bn 35.84 Bn - -1,651.00
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 2,002.00
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 29,091.00
10 X4 Pharmaceuticals 533.17 Mn 338.08 Mn 7.19 Mn 114,341.00

Historic Data

Download Data
DateValue
Jun 30, 2026 114,341.00
Dec 31, 2025 156,773.00
Sep 30, 2025 460,213.00
Jun 30, 2025 -1.40 Mn